Busulfan and cyclophosphamide (BuCy) is the standard myeloablative conditioning regimen for patients with acute myeloblastic leukemia (AML) undergoing allogeneic hematopoietic stem-cell transplantation (allo-HSCT).
Fludarabine and busulfan (FluBu) conditioning seems to have similar efficacy with less toxicity.
